Abstract
Panic disorder (PD) is a complex and heterogeneous psychiatric condition. Dysfunction within the serotonergic system has been hypothesized to play an important role in PD. The novel brain-specific serotonin synthesizing enzyme, tryptophan hydroxylase 2 (TPH2), which represents the rate-limiting enzyme of serotonin production in the brain, may therefore be of particular importance in PD. We investigated the TPH2 703G/T SNP for association with PD. Patients with PD (n = 108), and control subjects (n = 247), were genotyped for rs4570625 (TPH2 703G/T). Male and female subjects were analyzed separately. The severity of their symptoms was measured using the Spielberger state-trait anxiety inventory (STAI), panic disorder severity scale (PDSS), anxiety sensitivity index (ASI), acute panic inventory (API), and Hamilton’s rating scale for depression (HAMD). The genotype and allele frequencies of the PD patients and controls were analyzed using χ 2 statistics. There was a significant difference in the allele frequency in rs4570625 between the PD patients and normal controls. The T allele was significantly less frequent in the PD patients. We also found a significant association with rs4570625 in the female subgroup. There was no difference in symptom severity among the genotypes of this polymorphism. This result suggests that rs4570625 polymorphism may play a significant role in the pathogenesis of PD. Moreover, rs4570625 may have a gender-dependent effect on susceptibility to PD. Further studies are needed to replicate the association that we observed.
Similar content being viewed by others
References
Brown SM, Peet E, Manuck SB, Williamson DE, Dahl RE, Ferrell RE, Hariri AR (2005) A regulatory variant of the human tryptophan hydroxylase 2 gene biases amygdala reactivity. Mol Psychiatry 10:884–888 805
Canli T, Congdon E, Gutknecht L, Constable RT, Lesch KP (2005) Amygdala responsiveness is modulated by tryptophan hydroxylase 2 gene variation. J Neural Trans 112:1479–1485. doi:10.1007/s00702-005-0391-4
Chaouloff F (1993) Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Rev 18:1–32. doi:10.1016/0165-0173(93)90005-K
De Angelis L (2002) 5-HT2A antagonists in psychiatric disorders. Curr Opin Invest Drugs 3:106–112
De Luca V, Likhodi O, Van Tol HH, Kennedy JL, Wong AH (2005) Tryptophan hydroxylase 2 gene expression and romoter polymorphisms in bipolar disorder and schizophrenia. Psychopharmacol 183:378–382. doi:10.1007/s00213-005-0191-4
Dillon DJ, Gorman JM, Liebowitz MR, Fyer AJ, Klein DF (1987) Measurement of lactate-induced panic and anxiety. Psychiatry Res 20:97–105. doi:10.1016/0165-1781(87)90002-3
Eaton WW, Kessler RC, Wittchen HU, Magee WJ (1994) Panic and panic disorder in the United States. Am J Psychiatry 151:413–420
Fehr C, Schleicher A, Szegedi A, Anghelescu I, Klawe C, Hiemke C, Dahmen N (2001) Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy. Prog Neuropsychopharmacol Biol Psychiatry 25:965–982. doi:10.1016/S0278-5846(01)00171-3
First M, Spitzer RL, Gibbon M, William JB (1998) Structured clinical interview for DSM-IV axis I disorder-patient edition (SCID-I/P, version 2.0). Biometrics Research Department, New York State Psychiatric Institute, New York
Grant BF, Hasin DS, Stinson FS, Dawson DA, Goldstein RB, Smith S, Huang B, Saha TD (2006) The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67:363–374
Gutknecht L, Jacob C, Strobel A, Kriegebaum C, Müller J, Zeng Y, Markert C, Escher A, Wendland J, Reif A et al (2007) Tryptophan hydroxylase 2 gene variation influences personality traits and disorders related to emotional dysregulation. Int J Neuropsychopharmacol 10:309–320. doi:10.1017/S1461145706007437
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Han L, Nielsen DA, Rosenthal NE, Jefferson K, Kaye W, Murphy D, Altemus M, Humphries J, Cassano G, Rotondo A et al (1999) No coding variant of the tryptophan hydroxylase gene detected in seasonal affective disorder, obsessive-compulsive disorder, anorexia nervosa, and alcoholism. Biol Psychiatry 45:615–619. doi:10.1016/S0006-3223(98)00122-X
Hettema JM, Neale MC, Kendler KS (2001) A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158:1568–1578. doi:10.1176/appi.ajp.158.10.1568
Higashi S, Ohnuma T, Shibata N, Higashi M, Matsubara Y, Arai H (2007) No genetic association between tryptophan hydroxylase 2 gene polymorphisms and Japanese schizophrenia. Psychiatr Genet 17:123. doi:10.1097/YPG.0b013e328011c01a
Kawahara H, Yoshida M, Yokoo H, Nishi M, Tanaka M (1993) Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis. Neurosci Lett 162:81–84. doi:10.1016/0304-3940(93)90565-3
Kim W, Choi YH, Yoon KS, Cho DY, Pae CU, Woo JM (2006) Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population. Prog Neuropsychopharmacol Biol Psychiatry 30:1413–1418. doi:10.1016/j.pnpbp.2006.05.017
LeDoux JE, Cicchetti P, Xagoraris A, Romanski LM (1990) The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J Neurosci 10:1062–1069
Lim YJ, Yu BH, Kim JH (2007) Korean panic disorder severity scale: construct validity by confirmatory factor analysis. Depress Anxiety 24:95–102. doi:10.1002/da.20206
Lin YM, Chao SC, Chen TM, Lai TJ, Chen JS, Sun HS (2007) Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese. Arch Gen Psychiatry 64:1015–1024. doi:10.1001/archpsyc.64.9.1015
Lopez de Lara C, Brezo J, Rouleau G, Lesage A, Dumont M, Alda M, Benkelfat C, Turecki G (2007) Effect of tryptophan hydroxylase 2 gene variants on suicide risk in major depression. Biol Psychiatry 62:72–80. doi:10.1016/j.biopsych.2006.09.008
Maron E, Lang A, Tasa G, Liivlaid L, Töru I, Must A, Vasar V, Shlik J (2005) Associations between serotonin-related gene polymorphisms and panic disorder. The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 8:261–266
Maron E, Tõru I, Must A, Tasa G, Toover E, Vasar V, Lang A, Shlik J (2007) Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder. Neurosci Lett 411:180–184. doi:10.1016/j.neulet.2006.09.060
Mössner R, Freitag CM, Gutknecht L, Reif A, Tauber R, Franke P, Fritze J, Wagner G, Peikert G, Wenda B et al (2006a) The novel brain-specific tryptophan hydroxylase-2 gene in panic disorder. J Psychopharmacol 20:547–552. doi:10.1177/0269881106059704
Mössner R, Walitza S, Geller F, Scherag A, Gutknecht L, Jacob C, Bogusch L, Remschmidt H, Simons M, Herpertz-Dahlmann B et al (2006b) Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase 2 gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol 9:437–442. doi:10.1017/S1461145705005997
Mössner R, Müller-Vahl KR, Döring N, Stuhrmann M (2007) Role of the novel tryptophan hydroxylase 2 gene in Tourette syndrome. Mol Psychiatry 12:617–619. doi:10.1038/sj.mp.4002004
Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, Blier P, Diksic M (1997) Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 94:5308–5313. doi:10.1073/pnas.94.10.5308
Nutt DJ (1998) Antidepressants in panic disorder: clinical and preclinical mechanisms. J Clin Psychiatry 59(8):24–28 discussion 29
Papp LA, Martinez JM, Klein DF, Coplan JD, Norman RG, Cole R, de Jesus MJ, Ross D, Goetz R, Gorman JM (1997) Respiratory psychophysiology of panic disorder: three respiratory challenges in 98 subjects. Am J Psychiatry 154:1557–1565
Reiss S, Peterson RA, Gursky DM, McNally R (1986) Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther 24:1–8. doi:10.1016/0005-7967(86)90143-9
Reuter M, Kuepper Y, Hennig J (2007) Association between a polymorphism in the promoter region of the TPH2 gene and the personality trait of harm avoidance. Int J Neuropsychopharmacol 10:401–404. doi:10.1017/S1461145706007073
Savander V, Miettinen R, Ledoux JE, Pitkänen A (1997) Lateral nucleus of the rat amygdala is reciprocally connected with basal and accessory basal nuclei: a light and electron microscopic study. J Neurosci 77:767–781. doi:10.1016/S0306-4522(96)00513-1
Schruers K, Klaassen T, Pols H, Overbeek T, Deutz NE, Griez E (2000) Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients. Psychiatry Res 93:179–187. doi:10.1016/S0165-1781(00)00117-7
Schruers K, van Diest R, Overbeek T, Griez E (2002) Acute L-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients. Psychiatry Res 113:237–243. doi:10.1016/S0165-1781(02)00262-7
Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, Gorman JM, Papp LA (1997) Multicenter collaborative panic disorder severity scale. Am J Psychiatry 154:1571–1575
Shear MK, Rucci P, Williams J, Frank E, Grochocinski V, Vander Bilt J, Houck P, Wang T (2001) Reliability and validity of the panic disorder severity scale: replication and extension. J Psychiatr Res 35:293–296. doi:10.1016/S0022-3956(01)00028-0
Sheehan K, Lowe N, Kirley A, Mullins C, Fitzgerald M, Gill M, Hawi Z (2005) Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol Psychiatry 10:944–949. doi:10.1038/sj.mp.4001698
Spielberger CD (1983) STAI: manual for the stait-trait anxiety inventory. Consulting Psychologists Press, Palo Alto
Stutzmann GE, McEwen BS, LeDoux JE (1998) Serotonin modulation of sensory inputs to the lateral amygdala: dependency on corticosterone. J Neurosci 18:9529–9538
Taylor S, Koch WJ, Crockett DJ (1991) Anxiety sensitivity, trait anxiety, and the anxiety disorders. J Anxiety Disorders 5:293–311. doi:10.1016/0887-6185(91)90030-W
Telch MJ, Shermis MD, Lucas JA (1989) Anxiety sensitivity: unitary personality trait or domain-specific appraisals? J Anxiety Disorders 3:25–32. doi:10.1016/0887-6185(89)90026-1
Walther DJ, Bader M (2003) A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 66:1673–1680. doi:10.1016/S0006-2952(03)00556-2
Walther DJ, Peter JU, Bashammakh S, Hörtnagl H, Voits M, Fink H, Bader M (2003) Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299:76. doi:10.1126/science.1078197
Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J et al (1997) The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 54:305–309
Yoon HK, Yang JC, Lee HJ, Kim YK (2008) The association between serotonin-related gene polymorphisms and panic disorder. J Anxiety Disord 22:1529–1534
Zill P, Büttner A, Eisenmenger W, Bondy B, Ackenheil M (2004a) Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains. Eur Neuropsychopharmacol 14:282–284. doi:10.1016/j.euroneuro.2003.10.002
Zill P, Büttner A, Eisenmenger W, Möller HJ, Bondy B, Ackenheil M (2004b) Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol Psychiatry 56:581–586
Acknowledgments
This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (A040042).
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by Tatiana Foroud.
Rights and permissions
About this article
Cite this article
Kim, YK., Lee, HJ., Yang, JC. et al. A Tryptophan Hydroxylase 2 Gene Polymorphism is Associated with Panic Disorder. Behav Genet 39, 170–175 (2009). https://doi.org/10.1007/s10519-008-9254-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10519-008-9254-8